Follow
Philippe Riou
Philippe Riou
Verified email at crick.ac.uk
Title
Cited by
Cited by
Year
Proneural transcription factors regulate different steps of cortical neuron migration through Rnd-mediated inhibition of RhoA signaling
E Pacary, J Heng, R Azzarelli, P Riou, D Castro, M Lebel-Potter, C Parras, ...
Neuron 69 (6), 1069-1084, 2011
2252011
Cdc42 promotes transendothelial migration of cancer cells through β1 integrin
N Reymond, JH Im, R Garg, FM Vega, B Borda d’Agua, P Riou, S Cox, ...
Journal of Cell Biology 199 (4), 653-668, 2012
2062012
Rnd proteins: multifunctional regulators of the cytoskeleton and cell cycle progression
P Riou, P Villalonga, AJ Ridley
Bioessays 32 (11), 986-992, 2010
1312010
14-3-3 proteins interact with a hybrid prenyl-phosphorylation motif to inhibit G proteins
P Riou, S Kjær, R Garg, A Purkiss, R George, RJ Cain, G Bineva, ...
Cell 153 (3), 640-653, 2013
1192013
Atypical protein kinase Cι as a human oncogene and therapeutic target
PJ Parker, V Justilien, P Riou, M Linch, AP Fields
Biochemical pharmacology 88 (1), 1-11, 2014
1072014
Expression of T‐cadherin in tumor cells influences invasive potential of human hepatocellular carcinoma
P Riou, R Saffroy, C Chenailler, B Franc, C Gentile, E Rubinstein, ...
The FASEB journal 20 (13), 2291-2301, 2006
802006
An antagonistic interaction between PlexinB2 and Rnd3 controls RhoA activity and cortical neuron migration
R Azzarelli, E Pacary, R Garg, P Garcez, D Van Den Berg, P Riou, ...
Nature communications 5 (1), 3405, 2014
772014
aPKC inhibition by Par3 CR3 flanking regions controls substrate access and underpins apical-junctional polarization
EV Soriano, ME Ivanova, G Fletcher, P Riou, PP Knowles, K Barnouin, ...
Developmental cell 38 (4), 384-398, 2016
672016
Adenosine-binding motif mimicry and cellular effects of a thieno[2,3-d]pyrimidine-based chemical inhibitor of atypical protein kinase C isoenzymes
S Kjær, M Linch, A Purkiss, B Kostelecky, PP Knowles, C Rosse, P Riou, ...
Biochemical journal 451 (2), 329-342, 2013
622013
Rho GTPases and cancer cell transendothelial migration
N Reymond, P Riou, AJ Ridley
Rho GTPases: Methods and Protocols, 123-142, 2012
452012
Investigation in liver tissues and cell lines of the transcription of 13 genes mapping to the 16q24 region that are frequently deleted in hepatocellular carcinoma
P Riou, R Saffroy, J Comoy, M Gross-Goupil, JP Thiéry, JF Emile, ...
Clinical cancer research 8 (10), 3178-3186, 2002
422002
RhoC and ROCKs regulate cancer cell interactions with endothelial cells
N Reymond, JH Im, R Garg, S Cox, M Soyer, P Riou, A Colomba, ...
Molecular Oncology 9 (6), 1043-1055, 2015
342015
Analysis of chromosomal instability in pulmonary or liver metastases and matched primary hepatocellular carcinoma after orthotopic liver transplantation
M Gross‐Goupil, P Riou, JF Emile, R Saffroy, D Azoulay, I Lacherade, ...
International journal of cancer 104 (6), 745-751, 2003
322003
Regulation of polarized morphogenesis by protein kinase C iota in oncogenic epithelial spheroids
M Linch, M Sanz-Garcia, C Rosse, P Riou, N Peel, CD Madsen, E Sahai, ...
Carcinogenesis 35 (2), 396-406, 2014
292014
A cancer-associated mutation in atypical protein kinase Cι occurs in a substrate-specific recruitment motif
M Linch, M Sanz-Garcia, E Soriano, Y Zhang, P Riou, C Rosse, ...
Science signaling 6 (293), ra82-ra82, 2013
292013
Rnd3 induces stress fibres in endothelial cells through RhoB
U Gottesbühren, R Garg, P Riou, B McColl, D Brayson, AJ Ridley
Biology Open 2 (2), 210-216, 2012
262012
Rnd3-induced cell rounding requires interaction with Plexin-B2
B McColl, R Garg, P Riou, K Riento, AJ Ridley
Journal of cell science 129 (21), 4046-4056, 2016
232016
Analysis of alterations of WFDC1, a new putative tumour suppressor gene, in hepatocellular carcinoma
R Saffroy, P Riou, G Soler, D Azoulay, JF Emile, B Debuire, A Lemoine
European Journal of Human Genetics 10 (4), 239-244, 2002
222002
Fate and characterization of circulating tumor cells in a NOD/SCID mouse model of human hepatocellular carcinoma
O Scatton, F Chiappini, P Riou, A Marconi, R Saffroy, MP Bralet, ...
Oncogene 25 (29), 4067-4075, 2006
202006
The Rho family GEF FARP2 is activated by aPKCι to control tight junction formation and polarity
A Elbediwy, Y Zhang, M Cobbaut, P Riou, RS Tan, SK Roberts, C Tynan, ...
Journal of Cell Science 132 (8), jcs223743, 2019
132019
The system can't perform the operation now. Try again later.
Articles 1–20